Found: 5
Select item for more details and to access through your institution.
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 11, p. 2589, doi. 10.1007/s00277-020-04234-9
- By:
- Publication type:
- Article
Assessment of prolonged proteasome inhibition through ixazomib‐based oral regimen on newly diagnosed and first‐relapsed multiple myeloma: A real‐world Chinese cohort study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 9, p. 1, doi. 10.1002/cam4.7177
- By:
- Publication type:
- Article
Tumor-associated macrophages regulate the function of cytotoxic T lymphocyte through PD-1/PD-L1 pathway in multiple myeloma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 24, p. 4838, doi. 10.1002/cam4.4814
- By:
- Publication type:
- Article
Stanozolol improves the progression-free survival of patients with high-risk myelodysplastic syndrome after decitabine treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Notable roles of EZH2 and DNMT1 in epigenetic dormancy of the SHP1 gene during the progression of chronic myeloid leukaemia.
- Published in:
- Oncology Letters, 2017, v. 13, n. 6, p. 4979, doi. 10.3892/ol.2017.6050
- By:
- Publication type:
- Article